These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15738603)

  • 1. [Cytometric analysis of the relation between aneuploidy and expression of receptors for insulin growth factor I in child and adolescent osteosarcoma, after preliminary chemotherapy].
    Rytwiński K; Wnuk A; Woźniak W; Rychłowska M
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):275-81. PubMed ID: 15738603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between the expression of insulin-like growth factor I receptors and apoptosis after preliminary chemotherapy, in child and adolescent osteosarcoma].
    Rytwiński K; Wnuk A; Woźniak W; Rychłowska M
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):267-73. PubMed ID: 15738602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of DNA histograms and histopathologic assessment of necrosis after preoperative chemotherapy of osteosarcoma in children and youth].
    Rytwiński K; Wnuk A; Klepacka T; Bilska K
    Med Wieku Rozwoj; 2000; 4(2 Suppl 2):36-43. PubMed ID: 11178327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytometric assessment of apoptosis and aneuploidy in relation to survival time in osteosarcomas of children and adolescents].
    Rytwiński K; Woźniak W; Rychłowska M; Wnuk A
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1021-8. PubMed ID: 15951596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the correlation between proliferation defined by S-phase cell cycle and apoptosis after preoperative chemotherapy in osteosarcomas of children and adolescents].
    Rytwiński K; Wnuk A; Woźniak W; Rychłowska M; Bieńkowska M
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1029-36. PubMed ID: 15951597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.
    Bösing T; Roessner A; Hiddemann W; Mellin W; Grundmann E
    J Cancer Res Clin Oncol; 1987; 113(4):369-75. PubMed ID: 3474234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Flow cytometry estimate of s phase cell cycle and prognosis of osteosarcoma in children and adolescents].
    Wnuk A; Rytwinski K; Rychlowska M; Klepacka T; Michalak E
    Med Wieku Rozwoj; 2001; 5(3):283-90. PubMed ID: 12004161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
    Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
    Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aneuploidy and histopathological classification, according to the Musculoskeletal Tumour Society and WHO, of osteosarcoma in children and adolescents].
    Rytwinski K; Klepacka T; Wnuk A; Michalak E
    Med Wieku Rozwoj; 2000; 4(4):373-82. PubMed ID: 11228595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface receptor expression patterns in osteosarcoma.
    Hassan SE; Bekarev M; Kim MY; Lin J; Piperdi S; Gorlick R; Geller DS
    Cancer; 2012 Feb; 118(3):740-9. PubMed ID: 21751203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
    Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
    J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.
    Daqian W; Chuandong W; Xinhua Q; Songtao A; Kerong D
    Chem Biol Interact; 2015 Jul; 237():25-30. PubMed ID: 25980584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA cytometry of solitary and aneurysmal bone cysts and low malignancy and high malignancy central osteosarcomas. Current significance within the scope of morphologic diagnosis of intraosseous cystic and osteoblastic lesions].
    Werner M; Heintz A; Delling G
    Pathologe; 1996 Jan; 17(1):44-9. PubMed ID: 8685095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of comparing flow cytometry examination and histopathology in prognosing of osteogenic sarcoma - preliminary report].
    Klepacka T; Rytwinski K; Wnuk A; Michalak E; Wozniak W
    Med Wieku Rozwoj; 2000; 4(3):261-7. PubMed ID: 11093343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of osteosarcomas and cell aneuploidy in children and adolescents -- retrospective studies].
    Rytwinski K; Rychlowska M; Wnuk A; Klepacka T; Michalak E
    Med Wieku Rozwoj; 2001; 5(3):273-81. PubMed ID: 12004160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.